Immuron Share Price - IMRN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Immuron Ltd IMRN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0096 -0.27% 3.514 3.55 3.4674 3.55 3.5236 16:00:00
Bid Price Ask Price Spread Spread % News
2.52 4.80 2.28 47.5% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume
16 6,807  3.49  23,764 40,239
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100  3.51 USD

Immuron Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio
 15.53M 4.42M  -3.01M -0.90 - 4.42M
Dividends Per Share Dividend Yield
-  - 0.00% - -

more financials information »

News Immuron

Loading Messages....

Latest IMRN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

IMRN Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's lead product candidate, IMM-124E, is a proprietary immunomodulator agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.


Your Recent History
NASDAQ
IMRN
Immuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.